Autolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in the Jefferies Virtual London Healthcare Conference
November 2020– Dr. Christian Itin, chairman and chief executive officer, will participate in an analyst led fireside chat and host virtual one-on-one meetings at the Jefferies Virtual London Healthcare Conferenceat 11.25 am ET, 4.25 pm GMT. A live audio webcast of the fireside chat will be available on the investor relations section of the Company’s website at Autolus. An archived replay will be available for a period of 30 days after the conference.
- 7 December 2020 – Dr.
Christian Itin, chairman and chief executive officer, along with the Autolusclinical team, will host an investor call and webcast at 4.00 pm ET, 9.00 pm GMTto discuss presentations related to its AUTO1and AUTO3 programs, the company’s CAR T cell therapies being investigated in adult Acute Lymphoblastic Leukemia (ALL) and relapsed/ refractory diffuse large B cell lymphoma (DLBCL), respectively, during the ASH conference. To listen to the webcast and view the accompanying slide presentation, please go to Autolus. After the conference call, a replay will be available for a period of one week.
Vice President, Investor Relations and Corporate Communications
+44 (0) 7587 372 619
+44 (0) 7818 430877
Source: Autolus Therapeutics plc